HB 4423 requires the Oklahoma Health Care Authority to verify the immigration status of all Medicaid applicants using the federal SAVE system (or its successor) before approving benefits. It specifically mandates that the Authority notify U.S. Immigration and Customs Enforcement (ICE) if an applicant's status cannot be verified as lawful. This applies to all applicants, including adults applying for child-only Medicaid benefits on behalf of a child. The bill takes effect October 1, 2026, and does not change Medicaid eligibility criteria but adds a verification step for immigration status.
SB 1425 repeals three existing Oklahoma statutes related to health care workforce programs: 70 O.S. 2021 §2640 (Oklahoma Health Care Workers and Educators Assistance Program) and 74 O.S. 2021 §§3200.1-3200.2 (Health Care Workforce Resources Act). This bill eliminates the legal framework for these specific programs, which previously provided assistance to health care workers and educators. The repeal takes effect on November 1, 2026, and directly affects the administrative structure and operations of those programs. No new provisions or funding are created; the bill solely removes the existing laws.
HB 3644 (the Blake Burgess Act) requires hospitals with emergency departments and ambulatory surgical centers to implement standardized VTE (venous thromboembolism, or blood clot in veins) risk assessments for patients using nationally recognized tools and provide annual training to non-physician clinical staff. It mandates a statewide VTE registry managed by a private, nonprofit entity meeting specific criteria, which hospitals must report to starting July 2027 with data including patient age, zip code, sex, diagnosis details, and treatment. The registry collects information to improve VTE care quality, monitor outcomes, and inform state health reports, with hospitals required to submit data on VTE incidence, patient demographics, and treatment. The law directly affects hospitals, ambulatory surgical centers, and their clinical staff through new screening, training, and reporting obligations.
HB 3767 adds specific synthetic drugs and substances to Oklahoma's Schedule I and IV of controlled dangerous substances under state law. It directly affects anyone possessing, distributing, or using the newly listed compounds, including various fentanyl analogs (like para-fluorofentanyl), synthetic hallucinogens (like psilocybin and salvia), and other novel psychoactive substances. The bill amends Oklahoma's Controlled Dangerous Substances Act by expanding the official lists in Schedule I (substances with no medical use and high abuse potential) and Schedule IV (substances with accepted medical use but potential for abuse). This creates new legal prohibitions for these substances without requiring additional medical or legal exceptions.
HB 4294 requires health insurers in Oklahoma to provide equal coverage for epilepsy as for other conditions, prohibiting termination or non-renewal of policies solely due to an epilepsy diagnosis. It mandates coverage for seizure prevention devices, surgeries, or medical procedures prescribed by an epilepsy specialist when medically necessary to reduce SUDEP (sudden unexpected death in epilepsy) risk. The law applies to all individual and group health insurance plans covering medical/surgical benefits and takes effect November 1, 2026. This directly affects epilepsy patients and insurers offering such coverage in Oklahoma.
HB 3143 extends Oklahoma's moratorium on new medical marijuana business licenses (dispensaries, processors, growers) from August 1, 2026, to August 1, 2028. It requires existing license holders to get written approval from the Oklahoma Medical Marijuana Authority before transferring ownership, including submitting documentation to the Oklahoma State Bureau of Narcotics. Transfers must follow a 15-business-day timeline for license and registration changes, and applicants cannot submit transfer requests if disciplinary actions are pending. The bill also mandates that businesses provide a full inventory of all medical marijuana products during ownership changes and prohibits transfers without approval, with a 30-day window for pending applications to comply with new rules.
SB 1344 creates Oklahoma's Insulin Access and Affordability Program, administered by the State Department of Health, to increase access to affordable insulin for residents. The bill requires the Department to provide financial support to a nonprofit pharmaceutical manufacturer developing fast-acting biosimilar insulin, contingent on the manufacturer matching funds and agreeing to produce insulin at low cost without rebates (except as required by law). The agreement includes annual reporting on development progress and repayment terms if the insulin isn't produced and distributed as promised. This program directly affects Oklahoma residents needing insulin, public and private payors, and the specified nonprofit manufacturer.
HB 3194 protects Oklahoma pregnancy centers from state mandates requiring them to provide abortion services, contraception, or referrals. The bill prohibits state agencies from forcing centers to offer abortion-inducing drugs, post promotional materials for abortion, restrict services based on their pro-life stance, or interfere with their staffing decisions. It also allows centers to sue for triple damages (minimum $10,000) if state agencies violate these provisions. The law directly affects pregnancy centers - both general and medical - and state agencies that might attempt to impose such requirements. It focuses on preventing government compulsion, not restricting abortion access.
HB 2834 requires Oklahoma's Medicaid program to cover 96% of Medicare's payment rates for in-home physical, occupational, and speech therapy services. This directly affects Oklahoma Medicaid recipients needing these specific therapies by ensuring providers receive a standardized reimbursement rate. The bill sets a new reimbursement standard for these services, effective July 1, 2025, rather than expanding eligibility. It passed the Oklahoma House of Representatives with 64-25 support but did not secure emergency status.
HB 3130 prohibits Oklahoma state agencies, contractors, and public institutions from using state funds for gender transition procedures for minors, including allocation, referral, or contracting with providers offering such care. It also protects parents' rights by stating that withholding consent for gender transition procedures does not constitute child abuse or grounds for losing custody. The bill amends medical licensure laws to classify aiding or abetting gender transition procedures as unprofessional conduct, subjecting medical professionals to disciplinary action by licensing boards. These provisions apply directly to state-funded healthcare providers, minors receiving medical care, and licensed physicians or medical staff.
